Novo Nordisk A S

Altrafin AG NVO

Report date

6/30/2026

Quarter

2026 Q2

Filed

7/20/2026

Shares

139,963

Value ($000)

6,710

Weight

2.6%

2021 Q4 - 2026 Q2 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	7/20/2026	6,710	2.6%	139,963	6/30/2026
2026 Q1	4/14/2026	6,410	2.2%	174,413	3/31/2026
2025 Q4	2/13/2026	8,913	2.8%	175,183	12/31/2025
2025 Q3	2/17/2026	13,767	4.4%	248,105	9/30/2025
2025 Q2	2/17/2026	15,764	5.3%	228,399	6/30/2025
2025 Q1	2/17/2026	13,095	5.1%	188,583	3/31/2025
2024 Q4	2/17/2026	11,737	4.1%	136,446	12/31/2024
2024 Q3	2/17/2026	11,823	4.3%	99,295	9/30/2024
2024 Q2	2/17/2026	8,083	3.0%	56,627	6/30/2024
2024 Q1	2/17/2026	7,271	2.6%	56,630	3/31/2024
2023 Q4	2/17/2026	5,856	2.3%	56,611	12/31/2023
2023 Q3	2/17/2026	5,345	2.3%	58,772	9/30/2023
2023 Q2	2/17/2026	4,484	2.0%	27,711	6/30/2023
2023 Q1	2/17/2026	4,421	2.2%	27,780	3/31/2023
2022 Q4	2/17/2026	4,559	2.7%	33,689	12/31/2022
2022 Q3	2/17/2026	3,282	2.0%	32,943	9/30/2022
2022 Q2	2/17/2026	3,589	1.9%	32,209	6/30/2022
2022 Q1	2/17/2026	4,410	1.7%	39,715	3/31/2022
2021 Q4	2/17/2026	3,839	1.4%	34,277	12/31/2021